The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Association of Left Atrial Fibrosis Detected by Delayed-Enhancement Magnetic Resonance Imaging and the Risk of Stroke in Patients With Atrial Fibrillation
Open accessAbstract
Objectives This study tried to determine the association between left atrial (LA) fibrosis, detected using delayed-enhanced magnetic resonance imaging (DE-MRI), and the CHADS2 score (point system based on individual clinical risk factors including congestive heart failure, hypertension, age, diabetes, and prior stroke) variables, specifically stroke. Background In patients with atrial fibrillation (AF), conventional markers for the risk of stroke base their higher predictive effect on clinical features, particularly previous stroke history, and not individual LA pathophysiological properties. We aimed to determine the association between LA fibrosis, detected using DE-MRI, and the CHADS2 score variables, specifically stroke. Methods Patients with AF who presented to the AF clinic and received a DE-MRI of the LA were evaluated. Their risk factor profiles, including a CHADS2 score, were catalogued. The degree of LA fibrosis was determined as a percentage of the LA area. Any history of previous strokes, warfarin use, or cerebrovascular disease was recorded. Results A total of 387 patients, having a mean age of 65 ± 12 years, 36.8% female, were included in this study. A history of previous stroke was present in 36 (9.3%) patients. Those patients with previous strokes had a significantly higher percentage of LA fibrosis (24.4 ± 12.4% vs. 16.2 ± 9.9%, p < 0.01). A larger amount of LA fibrosis was also seen in those patients with a higher CHADS2 score (≥2: 18.7 ± 11.4 vs. <2: 14.7 ± 9.2, p < 0.01). A logistic regression analysis of all variables except strokes (CHAD score) demonstrated that LA fibrosis independently predicted cerebrovascular events (p = 0.002) and significantly increased the predictive performance of the score (area under the curve = 0.77). Conclusions Our preliminary, multicenter results suggest DE-MRI–based detection of LA fibrosis is independently associated with prior history of strokes. We propose that the amount of DE-MRI–determined LA fibrosis could represent a marker for stroke and a possible therapeutic target with potential applicability for clinical treatment for patients with AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Atrial Fibrillation Begets Atrial Fibrillation: A Study in Awake Chronically Instrumented Goats
Wijffels, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,494
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation: A Meta-Analysis
Hart, R. G., Benavente, O., McBride, R., & Pearce, L. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00003 · Cited by 1,638
Hemorrhagic Complications of Anticoagulant Treatment
Levine, M. N., Raskob, G., Landefeld, S., & Kearon, C. (2001) · Chest · doi:10.1378/chest.119.1_suppl.108s · Cited by 1,134
Oakes, R. S., Badger, T. J., Kholmovski, E. G., Akoum, N., Burgon, N. S., Fish, E. N., Blauer, J. J. E., Rao, S. N., DiBella, E. V. R., Segerson, N. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.811877 · Cited by 1,123
Self-citationAtrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090041008 · Cited by 1,108 · cited 1×
“Atrial fibrillation (AF) is associated with significant morbidity and mortality, primarily due to the increased risk of ischemic stroke (1).”
BackgroundNational Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events
Budnitz, D. S., Pollock, D. A., Weidenbach, K. N., Mendelsohn, A. B., Schroeder, T. J., & Annest, J. L. (2006) · JAMA · doi:10.1001/jama.296.15.1858 · Cited by 893
Gage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749 · cited 4×
“In addition, the HADS2 scheme has been shown to have a poor predictive power for moderate-risk patients, who compose the majority of patients stricken with AF (9).”
BackgroundInfluentialLi, D., Shinagawa, K., Pang, L., Leung, T. K., Cardin, S., Wang, Z., & Nattel, S. (2001) · Circulation · doi:10.1161/hc4601.099402 · Cited by 703
Cited by
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · Europace · doi:10.1093/europace/euw295 · Cited by 6,439
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights
Kornej, J., Börschel, C. S., Benjamin, E. J., & Schnabel, R. B. (2020) · Circulation Research · doi:10.1161/circresaha.120.316340 · Cited by 1,516
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Cabrera, J. A., Chen, S. A., Chugh, S. S., Corradi, D., D’Avila, A., Dobrev, D., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2016.05.028 · Cited by 771
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Cabrera, J. A., Chen, S. A., Chugh, S. S., Corradi, D., D'Avila, A., Dobrev, D., et al. (2016) · Europace · doi:10.1093/europace/euw161 · Cited by 762
Atrial Remodeling and Atrial Fibrillation
Nattel, S., & Harada, M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.555 · Cited by 736
Cardiac Fibrosis in Patients With Atrial Fibrillation
Dzeshka, M. S., Lip, G. Y. H., Snezhitskiy, V., & Shantsila, E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1313 · Cited by 552
Donal, E., Lip, G. Y. H., Galderisi, M., Goette, A., Shah, D., Marwan, M., Lederlin, M., Mondillo, S., Edvardsen, T., Sitges, M., et al. (2016) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jev354 · Cited by 341
Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy
Kottkamp, H. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht194 · Cited by 324
Cameli, M., Lisi, M., Righini, F. M., Massoni, A., Natali, B. M., Focardi, M., Tacchini, D., Geyer, A., Curci, V., Di Tommaso, C., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.10.049 · Cited by 283
Atrial fibrillation and cardiac fibrosis
Sohns, C., & Marrouche, N. F. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz786 · Cited by 270
Self-citationChao, T.-F., Liu, C.-J., Wang, K.-L., Lin, Y.-J., Chang, S.-L., Lo, L.-W., Hu, Y.-F., Tuan, T.-C., Chen, T.-J., Lip, G. Y. H., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.046 · Cited by 258
COCHET, H., MOURIES, A., NIVET, H., SACHER, F., DERVAL, N., DENIS, A., MERLE, M., RELAN, J., HOCINI, M., HAÏSSAGUERRE, M., et al. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12651 · Cited by 199
Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review
DENEKE, T., JAIS, P., SCAGLIONE, M., SCHMITT, R., DI BIASE, L., CHRISTOPOULOS, G., SCHADE, A., MÜGGE, A., BANSMANN, M., NENTWICH, K., et al. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12608 · Cited by 170
Female sex as an independent risk factor for stroke in atrial fibrillation: Possible mechanisms
Albert, C. M., Andreotti, F., Badimon, L., Van Gelder, I. C., Hylek, E. M., & Cove, C. L. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-04-0347 · Cited by 116
How will machine learning inform the clinical care of atrial fibrillation?
Siontis, K. C., Yao, X., Pirruccello, J. P., Philippakis, A. A., & Noseworthy, P. A. (2020) · Circulation Research · doi:10.1161/circresaha.120.316401 · Cited by 61
Haemers, P., Claus, P., & Willems, R. (2012) · Cardiology Research and Practice · doi:10.1155/2012/658937 · Cited by 7
“However, it is unclear if this association was also independent from LA dilation [38].”
BackgroundRelevanz der Magnetresonanztomographie für die Katheterablation von Vorhofflimmern
Mahnkopf, C., Mitlacher, M., & Brachmann, J. (2014) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-014-0327-5 · Cited by 3
Self-citation
Metadata
- Authors
- Daccarett, M., Badger, T. J., Akoum, N., Burgon, N. S., Mahnkopf, C., Vergara, G., Kholmovski, E., McGann, C. J., Parker, D., Brachmann, J., MacLeod, R. S., & Marrouche, N. F.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 57
- Issue
- 7
- Pages
- 831-838
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2106940213
- Cited by
- 386
- References
- 33
- FWCI
- 17.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.